Caris Life Sciences Stock

carislifesciences.comBioTechFunding to Date: $465MM

Operator of a biotechnology company specializing in cancer treatment agents. The company is a provider of molecular science focused on fulfilling the promise of precision medicine and facilitating a deeper understanding of cancer biology and other complex diseases through a suite of molecular profiling offerings assess DNA, RNA and proteins that reveal the molecular blueprint, enabling physicians and cancer patients to make more precise and personalized treatment decisions.

Register for Details

For more details on financing and valuation for Caris Life Sciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

David Halbert
Co-Founder, Chairman and Chief Executive Officer
David Spetzler Ph.D
President & Chief Scientific Officer
Thomas Parker
Chief Financial Officer and Senior Vice President
Ginger Appleberry JD
Chief Compliance Officer & Associate General Counsel
Ronald Merlino
Senior Vice President & Chief Information Officer
Stephanie Thomas
Chief of Staff, Executive Vice President & Office of the CEO
Brian Lamon Ph.D
Chief Business Officer & Head of BioPharma Business Development
Jim Abraham
Chief Data Officer & Senior Vice President

Board Members

Brian Brille JD
Caris Life Sciences
Danny Phillips
David Halbert
Caris Life Sciences
George Poste Ph.D
Jon Halbert
Caris Life Sciences
Jonathan Knowles Ph.D
Caris Life Sciences
Laurie Johansen JD
Caris Life Sciences
Peter Castleman
J.H. Whitney Capital Partners
Vijay Mohan
Sixth Street Specialty Lending

Other companies like Caris Life Sciences in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$289.42MM